Abakkus Large & Mid Cap Fund
Regular Plan · Growth · Large & Mid Cap · Scheme code 154478
Fund houseAbakkus Mutual Fund
CategoryLarge & Mid Cap
Plan & optionRegular · Growth
History—
Regular Plan · Growth · Large & Mid Cap · Scheme code 154478
Regular Plan · Growth
| Equity | 93.58% |
|---|---|
| Cash & Equivalents | 6.42% |
| Large Cap | 36.89% |
|---|---|
| Mid Cap | 36.84% |
| Small Cap | 19.85% |
| Number of stocks | 50 |
|---|---|
| Top 5 stocks | 14.87% |
| Top 10 stocks | 26.60% |
| Top 20 stocks | 46.76% |
| Lines in the filing | 52 |
| Largest holding | 3.72% |
|---|---|
| Largest sector | Banks 17.94% |
| Effective stocks | 53.1 |
| Sectors held | 26 |
| Cash | 6.42% |
Effective stocks is what the concentration works out to: a fund holding 50 names but most of its money in a few behaves like a fund of 53. Cash includes repo and TREPS, which every fund parks money in overnight.
| Banks | 17.94% |
|---|---|
| Pharmaceuticals & Biotechnology | 10.42% |
| Auto Components | 7.69% |
| Capital Markets | 7.63% |
| Cash & Equivalents | 6.42% |
| Finance | 5.70% |
| Automobiles | 5.39% |
| Retailing | 4.24% |
| Financial Technology (Fintech) | 4.12% |
| Realty | 3.12% |
| Aerospace & Defense | 2.13% |
| Industrial Products | 2.06% |
| Agricultural, Commercial & Construction Vehicles | 1.93% |
| Healthcare Services | 1.88% |
| Ferrous Metals | 1.81% |
| Power | 1.76% |
| Cement & Cement Products | 1.73% |
| Chemicals & Petrochemicals | 1.70% |
| Insurance | 1.63% |
| Consumer Durables | 1.57% |
Regular Plan · Growth · holdings
| # | Company | Sector | Shares held | Value ₹ cr | % of fund |
|---|---|---|---|---|---|
| 1 | Triparty Repo | Unclassified | — | 30 | 6.27% |
| 2 | ICICI Bank Limited | Banks | 136,593 | 18 | 3.72% |
| 3 | Kotak Mahindra Bank Ltd | Banks | 346,072 | 14 | 2.97% |
| 4 | One 97 Communications Limited | Financial Technology (Fintech) | 84,766 | 14 | 2.93% |
| 5 | Divi's Laboratories Limited | Pharmaceuticals & Biotechnology | 13,949 | 13 | 2.67% |
| 6 | Mankind Pharma Limited | Pharmaceuticals & Biotechnology | 50,075 | 13 | 2.58% |
| 7 | Lenskart Solutions Limited | Retailing | 182,010 | 12 | 2.57% |
| 8 | Multi Commodity Exchange of India Limited | Capital Markets | 35,815 | 12 | 2.43% |
| 9 | Axis Bank Limited | Banks | 93,103 | 11 | 2.35% |
| 10 | HDFC Bank Limited | Banks | 150,000 | 11 | 2.19% |
| 11 | Wheels India Limited | Auto Components | 47,892 | 11 | 2.19% |
| 12 | Billionbrains Garage Ventures Ltd | Capital Markets | 572,536 | 11 | 2.17% |
| 13 | Bharat Electronics Limited | Aerospace & Defense | 266,834 | 10 | 2.13% |
| 14 | Piramal Finance Limited | Finance | 49,778 | 10 | 2.09% |
| 15 | Endurance Technologies Limited | Auto Components | 38,097 | 10 | 2.08% |
| 16 | Cummins India Limited | Industrial Products | 21,033 | 10 | 2.06% |
| 17 | Aditya Birla Capital Limited | Finance | 251,172 | 10 | 1.97% |
| 18 | Karur Vysya Bank Limited | Banks | 290,306 | 9 | 1.94% |
| 19 | BEML Limited | Agricultural, Commercial & Construction Vehicles | 47,153 | 9 | 1.93% |
| 20 | The Phoenix Mills Limited | Realty | 47,645 | 9 | 1.90% |
| 21 | Tenneco Clean Air India Limited | Auto Components | 180,651 | 9 | 1.89% |
| 22 | Eicher Motors Limited | Automobiles | 12,864 | 9 | 1.89% |
| 23 | Rainbow Childrens Medicare Limited | Healthcare Services | 69,389 | 9 | 1.88% |
| 24 | Alkem Laboratories Limited | Pharmaceuticals & Biotechnology | 17,699 | 9 | 1.88% |
| 25 | Bajaj Auto Limited | Automobiles | 8,246 | 9 | 1.85% |
| 26 | Jindal Stainless Limited | Ferrous Metals | 117,818 | 9 | 1.81% |
| 27 | Equitas Small Finance Bank Limited | Banks | 1,252,963 | 9 | 1.78% |
| 28 | JSW Energy Limited | Power | 172,487 | 9 | 1.76% |
| 29 | Cipla Limited | Pharmaceuticals & Biotechnology | 63,228 | 9 | 1.75% |
| 30 | UltraTech Cement Limited | Cement & Cement Products | 7,694 | 8 | 1.73% |
Regular Plan · Growth · where the money sits
Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past returns do not predict future ones. Generated 31 Oct 2026.